24.9800.00% ( 0.000 )
Delay Closed: Nov 17, 16:08:15Valuation
Current ValuationThe current P/E ratio is 12.23, above the reasonable range, cheaper than 14.03% of the time in the past 5 years, and the industry ranks 14/53, the industry Median 6.96.
12.23xP/E
HK$24.98Stock price
HK$2.04Earnings per share
12.23xP/E
Stock priceHK$24.98Earnings per shareHK$2.04
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 11.07x
- Typical range
- 10.34x–11.96x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.96x
010203040
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.96x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
01093HKCSPC PHARMA | 10.63x | 128.56% | HK$90.91B |
02096HKSIMCERE PHARMA | 14.90x | 31.93% | HK$26.97B |
00867HKCMS | 13.47x | 41.06% | HK$23.80B |
01513HKLIVZON PHARMA | 12.23x | 17.45% | HK$22.18B |
00512HKGRANDPHARMA | 13.81x | 45.32% | HK$15.32B |
02005HKSSY GROUP | 14.41x | 24.61% | HK$7.31B |
00460HKSIHUAN PHARM | 19.94x | 322.94% | HK$6.93B |
03613HKTONGRENTANGCM | 12.75x | 15.96% | HK$4.60B |
01666HKTONG REN TANG | 10.92x | 21.20% | HK$3.86B |
00719HKSHANDONG XINHUA | 13.19x | -- | HK$3.51B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
